Cryosurgery during topical imiquimod: A successful combination modality for lentigo maligna

International Journal of Dermatology

Volumn 47, Issue 5, 2008, Pages 519-521

  Bassukas, I D ^a   Gamvroulia, C ^a   Zioga, A ^a   Nomikos, K ^a   Fotika, C ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; TUMOR ANTIGEN;

AGED; ANTIGEN PRESENTING CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; CASE REPORT; CELL MATURATION; CELL MIGRATION; CELLULAR IMMUNITY; CHEEK; CRYOSURGERY; DENDRITIC CELL; EFFECTOR CELL; HUMAN; HUMAN TISSUE; LYMPH NODE; MALE; MALIGNANT LENTIGO; REVIEW; SKIN BIOPSY; TUMOR CELL; TUMOR IMMUNITY; TUMOR VASCULARIZATION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, CUTANEOUS; AGED; AMINOQUINOLINES; COMBINED MODALITY THERAPY; CRYOSURGERY; HUMANS; HUTCHINSON'S MELANOTIC FRECKLE; MALE; SKIN NEOPLASMS;

EID: 42449129217     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2008.03562.x     Document Type: Review

References (18)

1. Cohen LM. Lentigo maligna and lentigo maligna melanoma. J Am Acad Dermatol 1995; 33: 923-936.
2. McKenna JK, Florell SR, Goldman GD, et al. Lentigo maligna/lentigo maligna melanoma. Current state of diagnosis and treatment. Dermatol Surg 2006; 32: 493-504.
3. Kuflik EG, Gage AA. Cryosurgery for lentigo maligna. J Am Acad Dermatol 1994; 31: 75-78.
4. Rajpar SF, Marsden JR. Imiquimod in the treatment of lentigo maligna. Br J Dermatol 2006; 155: 653-655.
5. Zalaudek I, Horn M, Richtig E, et al. Local recurrence in melanoma in situ: Influence of sex, age, site of involvement, and therapeutic modalities. Br J Dermatol 2003; 148: 703-708.
6. Bohler-Sommeregger K, Schuller-Petrovic S, Neumann R, et al. Cryosurgery of lentigo maligna. Plast Reconstr Surg 1992; 90: 436-440.
7. Hundeiker M, Sebastian G, Bassukas ID, et al. [Cryotherapy in dermatol] J Dtsch Dermatol Ges 2005; 3: 1009-1015.
8. Baust JG, Gage AA, Clarke D, et al. Cryosurgery - a putative approach to molecular-based optimization. Cryobiology 2004; 48: 190-204.
9. Baust JG, Gage AA. The molecular basis of cryosurgery. BJU Int 2005; 95: 1187-1191.
10. Seifert JK, Zhao J, Ahkter J, et al. Cryoablation of human colorectal cancer in vivo in a nude mouse xenograft model. Cryobiology 1998; 37: 30-37.
11. Sheen AJ, Poston GJ, Sherlock DJ. Cryotherapeutic ablation of liver tumours. Br J Surg 2002; 89: 1396-1401.
12. Forest V, Peoc'h M, Campos L, et al. Effects of cryotherapy or chemotherapy on apoptosis in a non-small-cell lung cancer xenografted into SCID mice. Cryobiology 2005; 50: 29-37.
13. Hollister WR, Mathew AJ, Baust JG, et al. Effects of freezing on cell viability and mechanisms of cell death in a human prostate cell lines. Mol Urol 1998; 2: 3-18.
14. Sauder DN. Immunomodulatory and pharmacologic properties of imiquimod. J Am Acad Dermatol 2000; 43: S6-S11.
15. Schön MP, Schön M. Immune modulation and apoptosis induction. Two sides of the antitumoral activity of imiquimod. Apoptosis 2004; 9: 291-298.
16. Sidbury R, Neuschler N, Neuschler E, et al. Topically applied imiquimod inhibits vascular tumor growth in vivo. J Invest Dermatol 2003; 121: 1205-1209.
17. Majewski S, Marczak M, Mlynarczyk B, et al. Imiquimod is a strong inhibitor of tumor cell-induced angiogenesis. Int J Dermatol 2005; 44: 14-19.
18. Crittenden MR, Thanarajasingam U, Vile RG, et al. Intratumoral immunotherapy: Using the tumour against itself. Immunology 2005; 114: 11-22.